Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients

NCT06437158 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Lymphatic Malformation

Interventions

DRUG: Bleomycin

Sponsor

West China Hospital